Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw

By: |
Published: July 20, 2020 5:45 PM

If the government can make sure that at least 20 per cent of the most high-risk population is immunised, then we can sort of create a control on the virus.

Epidemiologists have to work out the model as to what is the minimum number of people who need to be vaccinated when the vaccine comes out.Epidemiologists have to work out the model as to what is the minimum number of people who need to be vaccinated when the vaccine comes out.

India needs to draw up its immunisation strategy now itself on the administration of vaccine for COVID-19 on the population when it comes out, says biotechnology industry veteran Kiran Mazumdar-Shaw. “Vaccine is anybodys guess. Right from the end of this year to the middle of next year is the prediction, the Executive Chairperson of the city-headquartered biopharmaceuticals major Biocon Ltd said on the time-frame vis-a-vis its availability. She said some vaccine programmes have just started phase 3 clinical trials, with phase 1 and phase 2 ones having shown mixed signals. So, we are not sure, she said and, citing reports from the US, added: It looks like every vaccine needs two doses (per person). So, its not cheap, she told PTI here in an interview.

If the government can make sure that at least 20 per cent of the most high-risk population is immunised, then we can sort of create a control on the virus. But Mazumdar-Shaw also noted 20 per cent of Indian population is a huge 200 to 300 million people. Will the government bear it (cost)? she asked. So, one has to look at pharmacoeconomics point of view and immunological rationale, and find a balance between the two. Epidemiologists have to work out the model as to what is the minimum number of people who need to be vaccinated when the vaccine comes out. We cannot obviously vaccinate 1.3 billion people (the country’s total population) in such a short time because there wont be enough vaccine, she said. Even if the vaccine producers were going to make a billion doses, it cannot be done in one month.

“Maximum you can produce is 80 million to 100 million doses per month. So, which are the first 100 million people that will be vaccinated? Those are the kinds of planning we need to do now, she said. If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year, Mazumdar-Shaw said. On when she expected coronavirus cases to peak in the country, she said there were various forecasts and projections, and each part of the country was at a different level. They (forecasts and projections) are basically saying in the next two-and-half-months to four months, various parts of the country should be peaking. By the end of the year, all parts of the country would have peaked.

“By early December, we should have crossed the peak across the country. Every part of the country will peak at a different time, she said. Mazumdar-Shaw hastened to add: And then people dont know about the next wave. That is another worry. As on Monday morning, the country’s COVID-19 cases tally stands at 11,18,043 and the death toll reached 27,497.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Bihar reports highest single-day spike of 4,071 COVID-19 cases; 15 more fatalities push death toll to 465
2Centre asks states to not get ‘overawed’ by rise in daily Covid cases, test aggressively
3Covid vaccine panel to discuss procurement, logistics and priority groups on Wednesday